Literature DB >> 28966230

Difference in Postsurgical Prognostic Factors between Lung Adenocarcinoma and Squamous Cell Carcinoma.

Haruhiko Nakamura1, Hiroki Sakai1, Hiroyuki Kimura1, Tomoyuki Miyazawa1, Hideki Marushima1, Hisashi Saji1.   

Abstract

PURPOSE: The aim of this study was to compare the clinicopathologic prognostic factors between patients who underwent lung resection for adenocarcinoma (AD) and those with squamous cell carcinoma (SQ).
METHODS: A database of patients with lung AD or SQ who underwent surgery with curative intent in our department from January 2008 to December 2014 was reviewed. Associations between various clinicopathologic factors, postsurgical recurrence-free survival (RFS), and overall survival (OS) were analyzed to find significant prognostic factors.
RESULTS: A total of 537 lung cancer patients (AD, 434; SQ, 103) were included in this study. Although RFS was similar in patients with AD and SQ, OS was significantly poorer in those with SQ. Multivariate analysis in patients with AD revealed that age (≥69 vs. <69), lymphatic invasion, and histologic pleural invasion (p0 vs. p1-3) were associated with RFS, while gender and pleural invasion were associated with OS. In SQ, however, smoking, clinical stage, and pulmonary metastasis were associated with RFS in the multivariate analysis.
CONCLUSION: Since significant postoperative prognostic factors are quite different between lung AD and SQ, these two histologic types should be differently analyzed in a clinical study.

Entities:  

Keywords:  adenocarcinoma; lung cancer; prognosis; squamous cell carcinoma; survival

Mesh:

Year:  2017        PMID: 28966230      PMCID: PMC5738450          DOI: 10.5761/atcs.oa.17-00020

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  29 in total

Review 1.  Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis.

Authors:  Haruhiko Nakamura; Koji Ando; Takuo Shinmyo; Katsuhiko Morita; Atsushi Mochizuki; Noriaki Kurimoto; Shinobu Tatsunami
Journal:  Ann Thorac Cardiovasc Surg       Date:  2011-07-27       Impact factor: 1.520

2.  Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.

Authors:  Hiroyuki Sakurai; Hisao Asamura; Tomoyuki Goya; Kenji Eguchi; Yoichi Nakanishi; Noriyoshi Sawabata; Meinoshin Okumura; Etsuo Miyaoka; Yoshitaka Fujii
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

3.  Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu; Kyoichi Kaira; Toshiteru Nagashima; Kai Obayashi; Seshiru Nakazawa; Seiichi Kakegawa; Hitoshi Igai; Mitsuhiro Kamiyoshihara; Masahiko Nishiyama; Izumi Takeyoshi
Journal:  Surg Today       Date:  2016-01-19       Impact factor: 2.549

4.  Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.

Authors:  Shingo Usui; Yuko Minami; Toshihiro Shiozawa; Shinji Iyama; Kaishi Satomi; Shingo Sakashita; Yukio Sato; Masayuki Noguchi
Journal:  Lung Cancer       Date:  2013-09-12       Impact factor: 5.705

5.  Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.

Authors:  Michael F Nentwich; Benjamin A Bohn; Faik G Uzunoglu; Matthias Reeh; Alexander Quaas; Tobias J Grob; Daniel Perez; Asad Kutup; Maximilian Bockhorn; Jakob R Izbicki; Yogesh K Vashist
Journal:  J Thorac Cardiovasc Surg       Date:  2013-06-15       Impact factor: 5.209

6.  Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.

Authors:  Sai-Hong Ignatius Ou; Argyrios Ziogas; Jason A Zell
Journal:  J Thorac Oncol       Date:  2009-09       Impact factor: 15.609

7.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Authors:  Giorgio Vittorio Scagliotti; Purvish Parikh; Joachim von Pawel; Bonne Biesma; Johan Vansteenkiste; Christian Manegold; Piotr Serwatowski; Ulrich Gatzemeier; Raghunadharao Digumarti; Mauro Zukin; Jin S Lee; Anders Mellemgaard; Keunchil Park; Shehkar Patil; Janusz Rolski; Tuncay Goksel; Filippo de Marinis; Lorinda Simms; Katherine P Sugarman; David Gandara
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

8.  Female sex and long-term survival post curative resection for non-small-cell lung cancer.

Authors:  Richard Warwick; Michael Shackcloth; Neeraj Mediratta; Richard Page; James McShane; Mathew Shaw; Michael Poullis
Journal:  Eur J Cardiothorac Surg       Date:  2013-03-18       Impact factor: 4.191

9.  Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.

Authors:  Ie Ryung Yoo; Soo Kyo Chung; Hye Lim Park; Woo Hee Choi; Young Kyoon Kim; Kyo Young Lee; Young-Pil Wang
Journal:  Biomed Mater Eng       Date:  2014       Impact factor: 1.300

10.  The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer.

Authors:  Koichi Fukumoto; Tetsuo Taniguchi; Noriyasu Usami; Koji Kawaguchi; Takayuki Fukui; Futoshi Ishiguro; Shota Nakamura; Kohei Yokoi
Journal:  J Epidemiol       Date:  2014-12-06       Impact factor: 3.211

View more
  9 in total

1.  The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi-omics data.

Authors:  Sheng Yang; Tong Liu; Geyu Liang
Journal:  Mol Oncol       Date:  2020-07-11       Impact factor: 6.603

2.  Serum Carcinoembryonic Antigen Level Predicts Cancer-Specific Outcomes of Resected Non-Small Cell Lung Cancer With Interstitial Pneumonia.

Authors:  Masaki Tomita; Takanori Ayabe; Ryo Maeda; Kunihide Nakamura
Journal:  World J Oncol       Date:  2018-11-23

3.  Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules.

Authors:  Shingo Iwano; Hiroyasu Umakoshi; Shinichiro Kamiya; Kohei Yokoi; Koji Kawaguchi; Takayuki Fukui; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2019-06-07       Impact factor: 3.909

4.  Disparities in survival following surgery among patients with different histological types of N2-III non-small cell lung cancer: a Surveillance, Epidemiology and End Results (SEER) database analysis.

Authors:  Gang Jin; Xin Wang; Cai Xu; Jifeng Sun; Zhiyong Yuan; Jun Wang; Lujun Zhao
Journal:  Ann Transl Med       Date:  2020-10

5.  Somatic mutations combined with clinical features can predict the postoperative prognosis of stage IIIA lung adenocarcinoma.

Authors:  Jiuzhen Li; Xuefeng Lin; Xin Li; Weiran Zhang; Daqiang Sun
Journal:  Ann Transl Med       Date:  2022-02

6.  What's the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients.

Authors:  Wen Wang; Hui Liu; Guoli Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

7.  Squamous cell carcinoma predicts worse prognosis than adenocarcinoma in stage IA lung cancer patients: A population-based propensity score matching analysis.

Authors:  Bo Hao; Fang Li; Xiaoxia Wan; Shize Pan; Donghang Li; Congkuan Song; Ning Li; Qing Geng
Journal:  Front Surg       Date:  2022-08-23

8.  Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma.

Authors:  Peng Li; Hongliang Liu; Zhiqiang Zhang; Xiaodong Lv; Huijuan Wang; Jie Ma; Zhiyong Ma; Xiujuan Qu; Yue-E Teng
Journal:  Med Sci Monit       Date:  2018-01-31

9.  Risk assessment model and nomogram established by differentially expressed lncRNAs for early-stage lung squamous cell carcinoma.

Authors:  Zhulin Wu; Chensheng Ouyang; Lisheng Peng
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.